[1]
|
Sze, M.A., Tsuruta, M., Yang, S.J., et al. (2014) Changes in the Bacterial Microbiota in Gut, Blood, and Lungs Fol-lowing Acute LPS Instillation into Mice Lungs. PLoS ONE, 9, e111228. https://doi.org/10.1371/journal.pone.0111228
|
[2]
|
He, Y., Wen, Q., Yao, F., et al. (2016) Gut-Lung Axis: The Microbial Contributions and Clinical Implications. Critical Reviews in Microbiology, 43, 81-95. https://doi.org/10.1080/1040841X.2016.1176988
|
[3]
|
李立华, 邱新萍, 郭霞珍. 基于“四时五藏阴阳”理论整体论思想的研究不同含氧量对大鼠肺、肠组织VIP、CCK及P物质表达影响的实验观察[J]. 世界中医药, 2018, 13(5): 1095-1099.
|
[4]
|
温蕾. 从神经肽类相关物质中的实验研究探究脏腑相关的理论内涵[J]. 世界中医药, 2016, 11(11): 2396-2400.
|
[5]
|
Mjösberg, J. and Rao, A. (2018) Lung Inflammation Originating in the Gut. Science, 359, 36-37.
https://doi.org/10.1126/science.aar4301
|
[6]
|
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Pa-tients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[7]
|
新型冠状病毒肺炎诊疗方案(试行第五版 修正版) [J]. 中国中西医结合杂志, 2020, 40(2): 136-138.
|
[8]
|
World Health Organization (2020) Coronavirus Disease (COVID-19) Outbreak.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019
|
[9]
|
Guan, W., Ni, Z., Hu, Y., et al. (2020) Clin-ical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720.
|
[10]
|
Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513.
https://doi.org/10.1016/S0140-6736(20)30211-7
|
[11]
|
Zhang, H., Kang, Z., Gong, H., et al. (2020) The Digestive System Is a Potential Route of 2019-nCov Infection: A Bioinformatics 2 Analysis Based on Single-Cell Transcriptomes. Gut, 1-9. https://doi.org/10.1101/2020.01.30.927806
|
[12]
|
李萍, 赵四林, 陈煜枫, 等. 2例新型冠状病毒肺炎粪便SARS-CoV-2核酸阳性临床启示[J]. 国际检验医学杂志, 2020: 1-7.
|
[13]
|
Holshue, M.L., De Bolt, C., Lindquist, S., et al. (2020) First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine, 382, 929-936. https://doi.org/10.1056/NEJMoa2001191
|
[14]
|
国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第三版) [J]. 天津中医药, 2020. 37(1): 1-3.
|
[15]
|
江苏省新型冠状病毒肺炎中医辨治方案(试行第三版) [J]. 江苏中医药, 2020, 52(3): 1-2.
|
[16]
|
王传池, 吴珊, 江丽杰, 许伟明, 杨燕, 胡镜清. 全国各地区新型冠状病毒肺炎中医药诊治方案综合分析[J/OL].世界科学技术-中医药现代化: 1-7. http://kns.cnki.net/kcms/detail/11.5699.R.20200225.1702.006.html, 2020-02-27.
|
[17]
|
卢建珍, 裴静波, 潘建锋, 等. 基于“肺与大肠相表里”理论的宣肺通便方治疗功能性便秘的疗效及对血清SP、NO水平影响研究[J]. 广州中医药大学学报, 2020, 37(2): 233-238.
|
[18]
|
吴欢, 夏露, 孙永顺, 史苗颜, 徐贵华, 李凯, 石克华, 张惠勇, 张炜. 下法在新型冠状病毒肺炎中的运用[J]. 上海中医药杂志: 1-4.
|
[19]
|
薛鸿浩, 张惠勇, 鹿振辉, 等. 66例普通型新型冠状病毒肺炎恢复期患者中医临床特征分析[J]. 上海中医药杂志, 2020, 54(5): 18-21.
|
[20]
|
国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第七版) [J]. 实用中医内科杂志, 2020, 34(3): 3.
|